Page last updated: 2024-10-25

dapi and Cochlear Hearing Loss

dapi has been researched along with Cochlear Hearing Loss in 2 studies

DAPI: RN given refers to parent cpd.

Research Excerpts

ExcerptRelevanceReference
"Treatment of sensorineural hearing loss could be advanced using novel drug carriers such as hyperbranched polylysine (HBPL) or lipid nanocapsules (LNCs)."1.35Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. ( Kadlecova, Z; Klok, HA; Lenarz, T; Perrier, T; Saulnier, P; Scheper, V; Scholl, M; Stöver, T; Wolf, M, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahrt, EJ1
Perkel, DJ1
Tong, L1
Rubel, EW1
Portfors, CV1
Scheper, V1
Wolf, M1
Scholl, M1
Kadlecova, Z1
Perrier, T1
Klok, HA1
Saulnier, P1
Lenarz, T1
Stöver, T1

Other Studies

2 other studies available for dapi and Cochlear Hearing Loss

ArticleYear
Engineered deafness reveals that mouse courtship vocalizations do not require auditory experience.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Mar-27, Volume: 33, Issue:13

    Topics: Acoustic Stimulation; Acoustics; Animals; Animals, Newborn; Deafness; Diphtheria Toxin; Evoked Poten

2013
Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:6

    Topics: Animals; Cochlea; Drug Carriers; Ear, Inner; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Guinea

2009